搜尋





搜尋





市場行情
/
股票
/
rxrx
/

Recursion Pharmaceuticals Inc

RXRX

添加自選

3.000USD

+0.030+1.02%

收盤 07-29 16:00（美東）報價延遲15分鐘

1.58B總市值

虧損本益比TTM

Recursion Pharmaceuticals Inc

3.000

+0.030+1.02%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

RXRX 利潤表

您可以在這裡找到Recursion Pharmaceuticals Inc的年度或季度收入報告，以深入了解Recursion Pharmaceuticals Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q2

營業總收入

-56.11%6.47M

681.74%35.54M

-80.16%5.17M

33.34%19.22M

6.89%14.74M

-58.26%4.55M

147.62%26.08M

30.86%14.42M

13.68%13.79M

-20.36%10.89M

-19.96%10.53M

43.56%11.02M

127.53%12.13M

439.91%13.68M

419.34%13.16M

201.06%7.67M

108.16%5.33M

--2.53M

1270.43%2.55M

--2.56M

--186.00K

營業收入

-56.11%6.47M

681.74%35.54M

-80.16%5.17M

33.34%19.22M

6.89%14.74M

-58.26%4.55M

147.62%26.08M

30.86%14.42M

13.68%13.79M

-20.36%10.89M

-19.96%10.53M

43.56%11.02M

127.53%12.13M

439.91%13.68M

419.34%13.16M

201.06%7.67M

108.16%5.33M

--2.53M

1270.43%2.55M

--2.56M

--186.00K

主營業務成本

-42.78%12.49M

11.58%14.28M

21.59%14.69M

119.17%20.16M

95.50%21.83M

29.48%12.79M

11.05%12.08M

-1.95%9.20M

-10.30%11.17M

-8.85%9.88M

-29.41%10.88M

-34.05%9.38M

59.61%12.45M

--10.84M

--15.41M

--14.23M

--7.80M

----

營業費用

-34.51%134.98M

-23.60%143.87M

42.54%177.38M

70.02%195.45M

87.15%206.11M

71.47%188.31M

13.04%124.44M

23.97%114.96M

36.31%110.13M

47.10%109.82M

45.36%110.08M

30.49%92.73M

31.78%80.80M

10.62%74.66M

54.76%75.73M

63.45%71.06M

85.54%61.31M

--67.49M

--48.94M

136.25%43.48M

--33.05M

--18.40M

研發費用

-41.99%75.20M

5.62%95.94M

71.72%121.06M

83.69%128.64M

102.05%129.63M

52.45%90.83M

5.84%70.50M

30.99%70.03M

37.90%64.16M

47.81%59.58M

63.41%66.61M

39.35%53.46M

43.75%46.52M

-12.36%40.31M

22.88%40.76M

29.83%38.36M

34.67%32.37M

--46.00M

--33.17M

123.10%29.55M

--24.03M

--13.24M

折舊攤銷及損耗

1.77%19.67M

68.92%25.84M

120.12%21.04M

165.43%23.85M

161.23%19.33M

101.28%15.30M

25.79%9.56M

60.45%8.98M

97.23%7.40M

133.77%7.60M

154.27%7.60M

101.01%5.60M

35.16%3.75M

26.20%3.25M

16.03%2.99M

12.52%2.79M

87.82%2.78M

--2.58M

147.60%2.48M

--1.48M

--1.00M

營業利潤

32.85%-128.50M

41.05%-108.33M

-75.08%-172.20M

-75.28%-176.23M

-98.64%-191.37M

-85.76%-183.77M

1.20%-98.35M

-23.04%-100.54M

-40.30%-96.34M

-62.23%-98.93M

-59.09%-99.55M

-28.91%-81.72M

-22.66%-68.67M

6.12%-60.98M

-34.85%-62.57M

-54.88%-63.39M

-83.64%-55.98M

---64.96M

---46.40M

-124.67%-40.93M

---30.48M

---18.22M

淨非營業利息收入（費用）

利息收入

7.29%5.96M

35.45%6.26M

44.46%5.54M

66.66%5.44M

37.30%5.56M

2.17%4.62M

-22.95%3.83M

-34.11%3.27M

-13.13%4.05M

22.81%4.52M

171.52%4.98M

660.28%4.96M

5256.32%4.66M

--3.68M

3566.00%1.83M

2148.28%652.00K

443.75%87.00K

----

--50.00K

20.83%29.00K

--16.00K

--24.00K

利息費用

-31.10%350.00K

----

48.22%833.00K

21.83%480.00K

2440.00%508.00K

2226.92%605.00K

2148.00%562.00K

1415.38%394.00K

5.26%20.00K

100.00%26.00K

92.31%25.00K

85.71%26.00K

35.71%19.00K

--13.00K

-94.09%13.00K

-99.44%14.00K

-94.38%14.00K

----

--220.00K

487.09%2.50M

--249.00K

--426.00K

特殊收入（費用）

----

--0.00

-1208.33%-15.70M

----

0.00%-1.20M

--0.00

100.00%0.00

---1.20M

--0.00

100.00%0.00

---2.80M

----

--0.00

---827.00K

----

其他非經營性收入（費用）

225.04%784.00K

-805.62%-6.03M

983.00%5.25M

-61.48%-633.00K

-491.88%-627.00K

132.55%854.00K

-137.57%-594.00K

-775.86%-392.00K

255.34%160.00K

-1365.92%-2.62M

413.31%1.58M

928.57%58.00K

-45.07%-103.00K

-717.24%-179.00K

1162.07%308.00K

---7.00K

---71.00K

--29.00K

---29.00K

----

---324.00K

稅前利潤

39.74%-122.11M

39.57%-108.10M

-69.58%-162.25M

-75.29%-171.90M

-119.90%-202.65M

-84.32%-178.90M

-2.86%-95.67M

-27.81%-98.06M

-41.06%-92.15M

-68.82%-97.06M

-53.89%-93.02M

-17.03%-76.73M

-16.70%-65.33M

11.46%-57.49M

-27.45%-60.45M

-51.06%-65.56M

-82.24%-55.98M

---64.93M

---47.43M

-129.11%-43.40M

---30.72M

---18.94M

所得稅

-2813.92%-4.60M

185.71%20.00K

-98.20%3.00K

100.00%0.00

79.72%-158.00K

100.17%7.00K

--167.00K

---523.00K

---779.00K

---4.06M

----

除稅後利潤

41.97%-117.50M

39.56%-108.12M

-69.29%-162.25M

-76.23%-171.90M

-121.60%-202.49M

-92.38%-178.91M

-3.04%-95.84M

-27.13%-97.54M

-39.87%-91.37M

-61.75%-93.00M

-53.89%-93.02M

-17.03%-76.73M

-16.70%-65.33M

11.46%-57.49M

-27.45%-60.45M

-51.06%-65.56M

-82.24%-55.98M

---64.93M

---47.43M

-129.11%-43.40M

---30.72M

---18.94M

持續經營利潤

41.97%-117.50M

39.56%-108.12M

-69.29%-162.25M

-76.23%-171.90M

-121.60%-202.49M

-92.38%-178.91M

-3.04%-95.84M

-27.13%-97.54M

-39.87%-91.37M

-61.75%-93.00M

-53.89%-93.02M

-17.03%-76.73M

-16.70%-65.33M

11.46%-57.49M

-27.45%-60.45M

-51.06%-65.56M

-82.24%-55.98M

---64.93M

---47.43M

-129.11%-43.40M

---30.72M

---18.94M

歸属于母公司的淨利潤

41.97%-117.50M

39.56%-108.12M

-69.29%-162.25M

-76.23%-171.90M

-121.60%-202.49M

-92.38%-178.91M

-3.04%-95.84M

-27.13%-97.54M

-39.87%-91.37M

-61.75%-93.00M

-53.89%-93.02M

-17.03%-76.73M

-16.70%-65.33M

11.46%-57.49M

-27.45%-60.45M

-51.06%-65.56M

-82.24%-55.98M

---64.93M

---47.43M

-129.11%-43.40M

---30.72M

---18.94M

歸屬普通股東的淨利潤

41.97%-117.50M

39.56%-108.12M

-69.29%-162.25M

-76.23%-171.90M

-121.60%-202.49M

-92.38%-178.91M

-3.04%-95.84M

-27.13%-97.54M

-39.87%-91.37M

-61.75%-93.00M

-53.89%-93.02M

-17.03%-76.73M

-16.70%-65.33M

11.46%-57.49M

-27.45%-60.45M

-51.06%-65.56M

-82.24%-55.98M

---64.93M

---47.43M

-129.11%-43.40M

---30.72M

---18.94M

基本每股收益

55.84%-0.22

61.03%-0.21

-7.03%-0.36

-2.27%-0.41

-29.86%-0.50

-31.70%-0.53

22.46%-0.34

-3.17%-0.40

-13.56%-0.39

-30.45%-0.40

-25.51%-0.44

-2.53%-0.39

-3.95%-0.34

19.05%-0.31

-23.84%-0.35

-21.36%-0.38

-79.71%-0.33

---0.38

---0.28

-168.52%-0.31

---0.18

---0.12

稀釋每股收益

55.84%-0.22

61.03%-0.21

-7.03%-0.36

-2.27%-0.41

-29.86%-0.50

-31.70%-0.53

22.46%-0.34

-3.17%-0.40

-13.56%-0.39

-30.45%-0.40

-25.51%-0.44

-2.53%-0.39

-3.95%-0.34

19.05%-0.31

-23.84%-0.35

-21.36%-0.38

-79.71%-0.33

---0.38

---0.28

-168.52%-0.31

---0.18

---0.12

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Recursion Pharmaceuticals Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 RXRX 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Recursion Pharmaceuticals Inc 財年末的營收是多少？



Recursion Pharmaceuticals Inc 2025 財年營收為 74.68M，高於上一財年的 58.84M。

Recursion Pharmaceuticals Inc 最近一個季度的營收是多少？



Recursion Pharmaceuticals Inc 最近一個季度的營收為 6.47M，同比增長 -56.11%。

Recursion Pharmaceuticals Inc 全年的淨利潤是多少？



Recursion Pharmaceuticals Inc 2025 財年淨利潤為 -644.76M。

Recursion Pharmaceuticals Inc 上一季度的淨利潤是多少？



Recursion Pharmaceuticals Inc 最近一個季度的淨利潤為 -117.50M。

Recursion Pharmaceuticals Inc 年度營業利潤是多少？



Recursion Pharmaceuticals Inc 2025 財年的營業利潤為 -648.13M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。